T1	Participants 120 184	biochemical markers of bone metabolism and bone mineral density.
T2	Participants 375 439	bone mineral density and biochemical markers of bone metabolism.
T3	Participants 488 508	postmenopausal women
T4	Participants 542 586	four treatment groups: hysterectomized women
T5	Participants 692 715	Women with intact uteri
T6	Participants 1027 1049	HRT alone group (n=30)
T7	Participants 1106 1127	HRT + T group (n=27).
T8	Participants 1639 1948	The subjects were of similar age (54.0 +/- 0.8 years), height (64.0 +/- 0.3 in), weight (157.6 +/- 4.2 lb), and had similar baseline follicle-stimulating hormone (66.4 +/- 3.2 mIU/L), E2 (26.4 +/- 1.5 pg/ml), P4 (0.3 +/- 0.1 ng/ml), total T (19.0 +/- 1.5 ng/dL), and bioavailable T (3.7 +/- 0.3 ng/dL) levels.
